Treatment of intracerebral hemorrhage: a selective review and future directions

Area of Science:

• Neurosurgery
• Neurology
• Critical Care Medicine

Background:

• Intracerebral hemorrhage (ICH) is a severe neurological condition with high mortality and morbidity.
• Currently, no intervention demonstrates clear efficacy in improving patient outcomes after ICH.
• The economic impact of ICH is substantial, with annual treatment costs around US$ 12.7 billion.

Purpose of the Study:

• To provide a comprehensive understanding of current intracerebral hemorrhage treatment options.
• To discuss the pathophysiology and societal impact of ICH.
• To explore future therapeutic directions for managing ICH.

Main Methods:

• Selective review of existing literature on ICH treatments.
• Discussion of surgical interventions: open craniotomy, catheter-based thrombolytic therapy, endoscopic evacuation, and ultrasonic lysis.
• Analysis of key clinical trial results, including STICH and MISTIE.

Main Results:

• Current ICH treatments have not consistently demonstrated clear efficacy in improving outcomes.
• Various surgical and minimally invasive techniques are under investigation.
• Further research is needed to establish effective interventions for ICH.

Conclusions:

• Effective treatments for intracerebral hemorrhage remain elusive.
• Novel therapeutic strategies are crucial for improving functional independence in ICH survivors.
• Continued investigation into surgical and pharmacological interventions is warranted.